Swedish X-ray manufacturer, Arcoma, has hired Alexis Soh as its new Business Director in Asia. Her wide-ranging experience in business development, marketing and sales in Asia with the medical technology industry make her the ideal choice to grow Arcoma’s business in the Asia Pacific region.
Alexis Soh has worked in various segments of the industry at companies like Merck Sharp and Dome, Becton Dickinson, Hill-Room and Carl Zeiss, and have a track record of growing sales. Alexis will be based in Singapore.
Arcoma have many nice reference sites in Asia with Arcoma equipment at leading institutions in markets like Hong Kong, Singapore and Bangkok, but there is much untapped business potential to address that will help Arcoma grow the coming years.
“I am very pleased that we could attract Alexis to join Arcoma to take on the challenge to lead the expansion of our Asian business. She will be a great addition to the Arcoma team with her skills and experience of growing business in the region” says CEO Jesper Söderqvist.
“I am excited to join Arcoma that has a strong belief in product quality which has proven to be the leading industrial preference through the years. I look forward to grow the Arcoma presence and sales in the region working closely together with our Asia partners” comments Alexis Soh.
About Arcoma
Arcoma, with long experience in the industry, is a leading provider of integrated digital X-ray systems with high quality and advanced technology. Arcoma’s products offer the latest digital imaging technology combined with technically advanced moving positioning systems and ergonomic Scandinavian design. Arcoma offers the customers complete, configurable and functional digital x-ray systems. The company's products are sold through retailers as well as OEM customers and today there are over 3,500 of Arcoma’s X-ray systems installed worldwide. Arcoma is listed on Nasdaq First North.
For more information, please contact:
Jesper Söderqvist, Phone: +46 470 70 69 81, E-mail: jesper.soderqvist@arcoma.se
For more information about Arcoma please visit: www.arcoma.se
The information was submitted, through the CEO, for publication on November 31, 2019 at. 09 AM